Register

Radiation Oncology

Stage IV   

Questions discussed in this category

Would you deliver SBRT to the adrenal gland if a patient has already undergone contralateral adrenalectomy for oligometastatic NSCLC?
What would you anticipate with regard to potential adrenal toxicity when the patient has only 1 functioning adrenal gland? There are no other sites of...
3 Answers available
What is the rate of a cardiac events that you quote to a patient with preexisting heart disease going on trastuzumab for metastatic Her2+ breast cancer?
How does it vary for patients with a history of hypertension, diabetes, CHF, and coronary artery disease?
1 Answer available


Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-09-01
Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience.

Related Topics in Radiation Oncology

Copyright © 2024 theMednet
All Rights Reserved.